Here are 14 key notes on orthopedic and spine device companies from the past week.
Spinal Tech
Globus Medical reported clinical results from its seven-year trial follow-up on the SECURE-C Cervical Artificial Disc.
SpineGuard received the first order of PediGuard in China from XinRong Medical Group.
K2M, a company focused on achieving 3-D Total Body Balance, recorded its 300th surgical spine case using its Rhine Cervical Disc System.
Stryker subsidiary Howmedica Osteonics, an orthopedics manufacturer, settled a trade secret disagreement with Zimmer Biomet, according to Life Sciences Intellectual Property Review.
Four U.S. surgeons performed the first spine surgeries with Emerging Implant Technologies' implants.
The Internal Revenue Services is arguing in federal court to increase Medtronic's taxable income by around $1.4 billion related to its factories in Puerto Rico, according to the Star Tribune.
The global spinal cord stimulators market is set to grow at a 6.4 percent compound annual growth rate through 2027, according to a Future Market Insights report.
The cervical total disc replacement device market is anticipated to reach $1.75 billion by 2021, growing at a 23.1 percent compound annual growth rate.
Medtronic unveiled new telehealth solutions.
